We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.48B
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.65% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
MaxCyte
MXCT
$122M
| $6.91M | 0.02% |
988,227
-349
| -0% | -$2.38K |
|
|
DSKE
702
DELISTED
Daseke, Inc. Common Stock
DSKE
| $6.9M | 0.02% |
684,919
+682,480
| +27,982% | +$7.41M |
|
|
PDCE
703
DELISTED
PDC Energy, Inc.
PDCE
| $6.89M | 0.02% |
94,860
+6,546
| +7% | +$405K |
|
|
AVGOP
704
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
| $6.87M | 0.02% |
3,500
-1,200
| -26% | -$2.21M |
|
705
Marcus & Millichap
MMI
$1.18B
| $6.83M | 0.02% |
129,699
+406
| +0.3% | +$19.4K |
|
706
SunCoke Energy
SXC
$816M
| $6.83M | 0.02% |
766,552
+556,928
| +266% | +$4.39M |
|
707
Titan Machinery
TITN
$559M
| $6.79M | 0.02% |
240,276
-99
| -0% | -$3K |
|
708
Rocket Pharmaceuticals
RCKT
$382M
| $6.79M | 0.02% |
+427,851
| New | +$7.39M |
|
709
SM Energy
SM
$9.08B
| $6.75M | 0.02% |
173,157
+49,541
| +40% | +$1.79M |
|
710
O-I Glass
OI
$945M
| $6.71M | 0.02% |
508,825
-140,705
| -22% | -$1.84M |
|
711
The RealReal
REAL
$1.15B
| $6.66M | 0.02% |
917,664
+353,134
| +63% | +$3.12M |
|
712
Huntington Ingalls Industries
HII
$11B
| $6.65M | 0.02% |
33,342
-28,111
| -46% | -$5.49M |
|
713
Triumph Financial Inc
TFIN
$1.52B
| $6.63M | 0.02% |
70,466
-26,219
| -27% | -$2.58M |
|
714
Medtronic
MDT
$118B
| $6.61M | 0.01% |
59,526
-190,585
| -76% | -$20.1M |
|
|
EVBG
715
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $6.55M | 0.01% |
150,000
-616,428
| -80% | -$29.1M |
|
716
Fomento Económico Mexicano
FMX
$41.2B
| $6.54M | 0.01% |
78,967
-66,463
| -46% | -$5.24M |
|
|
EGRX
717
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.5M | 0.01% |
131,413
+2,526
| +2% | +$121K |
|
718
Archer Daniels Midland
ADM
$41B
| $6.45M | 0.01% |
71,464
+30,407
| +74% | +$2.37M |
|
719
Targa Resources
TRGP
$61.1B
| $6.44M | 0.01% |
85,387
+15,058
| +21% | +$951K |
|
720
Starbucks
SBUX
$111B
| $6.44M | 0.01% |
70,797
-43,474
| -38% | -$4.1M |
|
|
VGR
721
DELISTED
Vector Group Ltd.
VGR
| $6.42M | 0.01% |
533,450
+366,945
| +220% | +$4.08M |
|
722
Commercial Metals
CMC
$7.28B
| $6.32M | 0.01% |
151,851
+37,680
| +33% | +$1.42M |
|
|
SGMO
723
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $6.3M | 0.01% |
1,084,204
+599,932
| +124% | +$3.57M |
|
724
Korro Bio
KRRO
$204M
| $6.29M | 0.01% |
59,361
+3,340
| +6% | +$638K |
|
|
CYBR
725
DELISTED
CyberArk
CYBR
| $6.29M | 0.01% |
37,281
+957
| +3% | +$145K |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.